The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Mendelian randomization of blood lipids for coronary heart disease
Open accessAbstract
AIMS: To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization. METHODS AND RESULTS: We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a prior meta-analysis (threshold P < 2 × 10(-6)); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P ≤ 0.01. Mendelian randomization meta-analyses were conducted in 17 studies including 62,199 participants and 12,099 CHD events. Both the unrestricted and restricted allele scores for LDL-C (42 and 19 SNPs, respectively) associated with CHD. For HDL-C, the unrestricted allele score (48 SNPs) was associated with CHD (OR: 0.53; 95% CI: 0.40, 0.70), per 1 mmol/L higher HDL-C, but neither the restricted allele score (19 SNPs; OR: 0.91; 95% CI: 0.42, 1.98) nor the unrestricted HDL-C allele score adjusted for triglycerides, LDL-C, or statin use (OR: 0.81; 95% CI: 0.44, 1.46) showed a robust association. For triglycerides, the unrestricted allele score (67 SNPs) and the restricted allele score (27 SNPs) were both associated with CHD (OR: 1.62; 95% CI: 1.24, 2.11 and 1.61; 95% CI: 1.00, 2.59, respectively) per 1-log unit increment. However, the unrestricted triglyceride score adjusted for HDL-C, LDL-C, and statin use gave an OR for CHD of 1.01 (95% CI: 0.59, 1.75). CONCLUSION: The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Furthermore, Mendelian randomization studies have demonstrated that long-term exposure to lower LDL-C levels is associated with a much lower risk of CV events as compared with shorter-term exposure to lower LDL-C (as achieved, for example, in randomized trials) [48,52].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [48]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous epidemiological studies, Mendelian randomization studies, and RCTs have consistently demonstrated a log-linear relationship between the absolute changes in plasma LDL-C and the risk of ASCVD [34,45-50].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Non-HDL-C also includes the atherogenic TG-rich lipoproteins (VLDL, IDL and remnants), which is essential considering the recent information from genome-wide association studies (GWASs) and Mendelian randomization 76,86 - 89 supporting TGs and remnant particles as causative factors in atherogenesis.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [89]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At a more extreme level, while both CETP inhibitors and HMGCR lower CHD through the pharmacological reductions of apolipoprotein B 22 , their metabolomic signatures differ wildly 68 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The approach outlined here to obtaining a scaling estimate has generally held true for lipid-lowering therapies and risk of cardiovascular disease 22,23,40,92 but there are several potential reasons why the derivation of such a scaling for other therapeutic target-indication pairs may pose a challenge.”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [22]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N., & Davey Smith, G. (2008) · Statistics in Medicine · doi:10.1002/sim.3034 · Cited by 4,618 · cited 3×
“Moreover, at a population level the randomized allocation of parental alleles at conception tends to balance confounding factors among groups of differing genotypes.(9,10) Where a polymorphism is”
Self-citationBiological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citationEffects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139 · cited 1×
“the negative findings from clinical trials may have arisen from inadequate selection of drug targets or drug molecules.(6,8) Given this uncertainty, it remains unclear whether elevating HDL-C or reducing”
Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833 · cited 1×
“studies has been established as causal based on randomized trials of LDL-C-lowering drugs.(1,2) In contrast, uncertainty existson the causal relevance of high-density lipoprotein cholesterol (HDL-C) and trigly-”
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206797 · Cited by 2,022
Using multiple genetic variants as instrumental variables for modifiable risk factors
Palmer, T. M., Lawlor, D. A., Harbord, R. M., Sheehan, N. A., Tobias, J. H., Timpson, N. J., Smith, G. D., & Sterne, J. A. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280210394459 · Cited by 1,289 · cited 2×
“This should increase power, because each additional SNP contributes incrementally to the explained variance in the lipid fraction of interest and reduces the lack of specificity often observed with single SNPs, because the effects on traits other than the lipid fraction of interest should be small, non-systematic, and…”
Self-citationRemnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115
Cited by
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Self-citationMach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Bowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
“However, a more liberal Mendelian randomization analysis including genetic variants associated with other lipid fractions (in particular, triglycerides) did suggest a causal effect of HDL-c on CAD risk (Holmes et al., 2015).”
Background2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
“In contrast, Mendelian randomization studies do not provide compelling evidence that HDL-C is causally associated with the risk of ASCVD.(49,61,62) However, this evidence must be interpreted with caution because most genetic variants associated with HDL-C are also associated with directionally opposite changes in TGs,…”
Metadata
- Authors
- Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., Dale, C. E., Padmanabhan, S., Finan, C., Swerdlow, D. I., Tragante, V., van Iperen, E. P. A., Sivapalaratnam, S., Shah, S., Elbers, C. C., Shah, T., Engmann, J., Giambartolomei, C., White, J., Zabaneh, D., Sofat, R., McLachlan, S., on behalf of the UCLEB consortium, Doevendans, P. A., Balmforth, A. J., Hall, A. S., North, K. E., Almoguera, B., Hoogeveen, R. C., Cushman, M., Fornage, M., Patel, S. R., Redline, S., Siscovick, D. S., Tsai, M. Y., Karczewski, K. J., Hofker, M. H., Verschuren, W. M., Bots, M. L., van der Schouw, Y. T., Melander, O., Dominiczak, A. F., Morris, R., Ben-Shlomo, Y., Price, J., Kumari, M., Baumert, J., Peters, A., Thorand, B., Koenig, W., Gaunt, T. R., Humphries, S. E., Clarke, R., Watkins, H., Farrall, M., Wilson, J. G., Rich, S. S., de Bakker, P. I. W., Lange, L. A., Davey Smith, G., Reiner, A. P., Talmud, P. J., Kivimäki, M., Lawlor, D. A., Dudbridge, F., Samani, N. J., Keating, B. J., Hingorani, A. D., & Casas, J. P.
- Affiliations
- University College London (GB)
- University Medical Center Utrecht (NL)
- University of Warwick (GB)
- University of Bristol (GB)
- McMaster University (CA)
- University of Leicester (GB)
- London School of Hygiene & Tropical Medicine (GB)
- University of Glasgow (GB)
- Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, The Netherlands
- Amsterdam UMC Location University of Amsterdam (NL)
- Children's Hospital of Philadelphia (US)
- University of Edinburgh (GB)
- University of Leeds (GB)
- University of North Carolina at Chapel Hill (US)
- Baylor College of Medicine (US)
- University of Vermont (US)
- The University of Texas Health Science Center at Houston (US)
- Brigham and Women's Hospital (US)
- University of Washington (US)
- University of Minnesota (US)
- Stanford Medicine (US)
- University Medical Center Groningen (NL)
- National Institute for Public Health and the Environment (NL)
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
- Lund University (SE)
- The Royal Free Hospital (GB)
- School of Social and Community Medicine, University of Bristol
- Genetic Epidemiology Group, Institute of Cardiovacular Science, Faculty of Population Healh Sciences, University College London, 1–19 Torrington Place, London WC1E 6BT, UK
- Helmholtz Munich (DE)
- Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany
- University of Oxford (GB)
- University of Mississippi Medical Center (US)
- University of Virginia (US)
- Department of Medical Genetics, Division of Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
- MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK
- Fred Hutch Cancer Center (US)
- Department of Epidemiology and Public Health, University College London, 1–19 Torrington Place, London WC1E 6BT, UK
- Corresponding author
- Holmes, Michael V.
- ORCID
- Holmes, Michael V.
- Asselbergs, Folkert W.
- Palmer, Tom M.
- Drenos, Fotios
- Lanktree, Matthew B.
- Nelson, Christopher P.
- Dale, Caroline E.
- Padmanabhan, Sandosh
- Finan, Chris
- Swerdlow, Daniel I.
- Tragante, Vinicius
- Sivapalaratnam, Suthesh
- Shah, Sonia
- Elbers, Clara C.
- Shah, Tina
- Engmann, Jorgen
- Giambartolomei, Claudia
- White, Jon
- Zabaneh, Delilah
- Sofat, Reecha
- McLachlan, Stela
- Doevendans, Pieter A.
- Hall, Alistair S.
- North, Kari E.
- Almoguera, Berta
- Hoogeveen, Ron C.
- Cushman, Mary
- Fornage, Myriam
- Patel, Sanjay R.
- Redline, Susan
- Siscovick, David S.
- Tsai, Michael Y.
- Karczewski, Konrad J.
- Verschuren, W. Monique
- Bots, Michiel L.
- Melander, Olle
- Dominiczak, Anna F.
- Morris, Richard
- Price, Jackie
- Baumert, Jens
- Peters, Annette
- Thorand, Barbara
- Gaunt, Tom R.
- Humphries, Steve E.
- Watkins, Hugh
- Farrall, Martin
- Wilson, James G.
- Rich, Stephen S.
- Lange, Leslie A.
- Reiner, Alex P.
- Talmud, Philippa J.
- Lawlor, Debbie A.
- Dudbridge, Frank
- Samani, Nilesh J.
- Keating, Brendan J.
- Hingorani, Aroon D.
- Casas, Juan P.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-28
- Volume
- 36
- Issue
- 9
- Pages
- 539-550
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- PMC
- PMC4344957
- OpenAlex
- W2159738130
- Cited by
- 748
- References
- 36
- Citations by year
- 2026: 35 · 2025: 58 · 2024: 69 · 2023: 63 · 2022: 67 · 2021: 94 · 2020: 77 · 2019: 66 · 2018: 53 · 2017: 58 · 2016: 55 · 2015: 32 · 2014: 18
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- European Heart Journal (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Bristol Research (University of Bristol) (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- UniSA Research Outputs Repository (University of South Australia) (acceptedVersion, cc-by-nc)
- Open Access at Essex (University of Essex) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Brunel University Research Archive (BURA) (Brunel University London) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Site cant be reached (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- UNC Libraries
- Funders
- U.S. Department of Health and Human Services (42129‐32, 42107-26, 32108‐9, 32118-32119, 32115, 32111‐13, 32100‐2, 44221, 32105‐6, 32122, 24152)
- AstraZeneca
- GlaxoSmithKline
- Queen Mary University of London
- London School of Hygiene and Tropical Medicine
- Wellcome Trust (090532, 090532/Z/09/Z, 090532/Z/09/)
- Government of the United Kingdom
- National Institute for Health and Care Research
- British Heart Foundation (LSHM-CT-2007-037273, G0802432, 090532/Z/09/Z, CH98001, RG/13/16/30528, PG/07/133/24260, RG/08/008/25291, BHF RG 08/008, PG/07/133/24260, RG/07/005, RG 08/008, RG/10/12/28456, RG/07/005/23633, PG/13/66/30442, RG/13/2/30098, PG/07/131/24254)
- Research Councils UK
- University College London
- European Commission (LSHM-CT-2007–037273)
- Rosetrees Trust
- University of Bristol
- European Foundation for the Study of Diabetes
- Deutsche Forschungsgemeinschaft (TH-784/2–2)
- ZonMw
- Academy of Finland
- Bundesministerium für Bildung und Forschung (01GS0834)
- Hjärt-Lungfonden (RG/10/12/28456)
- Karolinska Institutet
- Knut och Alice Wallenbergs Stiftelse
- Stockholms Läns Landsting (560183)
- Universitetet i Oslo
- Universität Ulm
- National Institutes of Health (n01wh32105-27-0-1, n01hc95164-17-0-1, n01wh32108-30-0-1, n01wh32100-28-0-1, n01hc55021-47-0-1, n01wh32118-27-0-1, 32122, n01hc95165-34-0-1, n01hc55020-39-0-0, 32111‐13, n01hc55016-37-0-0, n01hc055022-024, n01hc95161-24-0-1, 32108‐9, 42129‐32, n01hc095169-003, NHLBI 33014, n01wh44221-7-0-1, 42107–26, n01wh42129-23-0-1, n01hc65226-6-0-0, n01hc95166-21-0-1, n01wh32111-28-0-1, n01wh32115-26-0-1, N01 WH 44221, n01wh22110-38-0-0, N01-WH-3-2115, n01hc95162-31-0-1, N01WH24152, 32118-32119, n01hc55019-35-0-1, 44221, 32115, n01hc95168-27-0-1, 32100‐2, n01hc95160-18-0-1, n01hc095167-000, n01wh24152-12-0-0, n01hc55018-38-0-1, n01hc95163-22-0-1, n01wh32122-31-0-1, N01-WH-3-2122, n01wh42107-22-0-1, n01hc95159-40-0-1, 23633, 24152, N01WH42129-32, N01-WH-32108-9, N01WH 32111-13, N01 WH 32105-6, N01 WH022110, N01-WH-32100-2, N01-WH-42107-26, N01WH 32118-32119, n01hc55015-48-0-1, 32105-6)
- U.S. Public Health Service (HHSN268200960009C, 33014)
- Medical Research Council (MR/K013351/1, MR/K006584/1, RG/10/12/28456, MR/L01629X/1, MR/K006215/1, WC1E 6BT, G0802432)
- Economic and Social Research Council (ES/J023299/1)
- World Cancer Research Fund
- Agentschap NL (grant IGE05012, IGE05012)
- Sahlgrenska Akademin
- Münchner Zentrum für Gesundheitswissenschaften
- National Institute on Aging (R01 AG1764406 S1, RG/10/12/28456, R01AG017644)
- National Heart, Lung, and Blood Institute (33014, N01-HC55022, N01-HC-65226, N01 HC-95159, N01-HC-95160, N01 HC055016, N01-HC-55018, N01-HC095169, 32100‐2, N01 HC-95168, 32118‐32119, N01 HC95167, N01 HC 55020, (N01-HC-95163, 32118, N01 HC 55019, N01 HC-95161, N01 HC95165, N01HC95164, N01 HC055020, 42107‐26, N01-HC-095159, N01 HC055018, 32119, 24152, 32105–6, RG/10/12/28456, 32108‐9, N01-HC55016, 32111–13, 32115, N01 HC055022, N01 HC065226, 42129‐32, HL36310, N01 HC055019, N01‐HC‐95166, 32122, N01‐HC‐55015, N01 HC-95162, N01-HC55021, N01 HC055021, N01 HC055015, R01HL036310, 44221, N01 HC95169)
- National Center for Research Resources (UL1RR024156, RR024156)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- coronary artery disease, HDL cholesterol, triglycerides, LDL cholesterol, serum lipids, single nucleotide polymorphisms, instrumental variables, statin use, genetic risk factors, lipid-lowering therapy, cardiovascular risk prediction, triglyceride-lowering therapy, LDL-C lowering therapy
- MeSH terms
- Coronary Artery Disease, Female, Gene Frequency, Genotype, Humans, Cholesterol, HDL, Male, Middle Aged, Triglycerides, Case-Control Studies, Risk Assessment, Polymorphism, Single Nucleotide, Mendelian Randomization Analysis, Genotyping Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mendelian randomization of blood lipids for coronary heart disease. https://app.cochat.ai/papers/10.1093/eurheartj/eht571
- The paper
- Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., Dale, C. E., Padmanabhan, S., Finan, C., Swerdlow, D. I., Tragante, V., van Iperen, E. P. A., Sivapalaratnam, S., Shah, S., Elbers, C. C., Shah, T., Engmann, J., Giambartolomei, C., White, J., . . . Casas, J. P. (2015). Mendelian randomization of blood lipids for coronary heart disease. European Heart Journal. https://doi.org/10.1093/eurheartj/eht571
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.